LY 171883, a CysLT1 Receptor (leukotriene D4) antagonist, has been shown to displace oleic acid binding to fatty-acid-binding protein (FABP) which may be involved in fatty acid metabolism. Studies suggest that this compound contains structural
LY 171883, a CysLT1 Receptor (leukotriene D4) antagonist, has been shown to displace oleic acid binding to fatty-acid-binding protein (FABP) which may be involved in fatty acid metabolism. Studies suggest that this compound contains structural
Application These are wiper pistons compatible with most fluids. A piston is inserted into the cartridge after it has been loaded with fluid to ensure uniform dispensing, prevent dripping, and eliminate waste by wiping barrel walls clean as fluid
Application These are wiper pistons compatible with most fluids. A piston is inserted into the cartridge after it has been loaded with fluid to ensure uniform dispensing, prevent dripping, and eliminate waste by wiping barrel walls clean as fluid
L-DOPS, also called L-threo 3,4-Dihydroxyphenylserine or droxidopa is a catecholamine. L-DOPS has many clinical advantages and may be useful for treating norepinephrine deficiency.
L-DOPS, also called L-threo 3,4-Dihydroxyphenylserine or droxidopa is a catecholamine. L-DOPS has many clinical advantages and may be useful for treating norepinephrine deficiency.
L-DOPS, also called L-threo 3,4-Dihydroxyphenylserine or droxidopa is a catecholamine. L-DOPS has many clinical advantages and may be useful for treating norepinephrine deficiency.
L-DOPS, also called L-threo 3,4-Dihydroxyphenylserine or droxidopa is a catecholamine. L-DOPS has many clinical advantages and may be useful for treating norepinephrine deficiency.